Delivery Order SPE2DB22D3501-SPE2DB24FWX62

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,104.49 firm-fixed-price contract is for the supply of KERENDIA 10 MG TABLET 90S, a prescription medication. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,068.15 firm fixed price delivery order is for the supply of KERENDIA 10 MG TABLET 90S, a pharmaceutical product. The award has an ultimate completion date of April 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,234.75 delivery order contract is for the supply of the medication KERENDIA 10 MG TABLET 30S. The contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,676.06 firm fixed-price delivery order contract is for the supply of KERENDIA 10 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of December 6, 2024 and was awarded on December 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,712.13, is for the delivery of KERENDIA 10 MG TABLET 30S, a medical product. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $35,050.32, is for the delivery of KERENDIA 10 MG TABLET 90S, a pharmaceutical product. This is a firm fixed-price delivery order contract with a completion date of July 8, 2024. The contract is not designated as a set-aside award. Amerisourcebergen holds a larger Indefinite...
This federal contract award, valued at $1,146.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KERENDIA 10 MG TABLET 30S, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of April 16, 2025. The contract is not set-aside and was awarded through open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award is a Delivery Order valued at $23,746.09, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KERENDIA 10 MG TABLET 30S, a pharmaceutical product, with a completion date of May 27, 2025. The contract is a Firm Fixed Price arrangement and is not set aside for any specific business designation. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $2,004.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order contract with a Firm Fixed Price pricing type, with an ultimate completion date of March 27, 2025. The contract provides for the delivery of 4567707917 KERENDIA 10 MG TABLET 30S, a pharmaceutical product, to support the DLA's medical supply needs. Amerisourcebergen...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,087.58, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), which is a $999,999,999 IDC that runs through November 2026. The contract is for the supply of the pharmaceutical product KERENDIA 10 MG TABLET 90S to support military healthcare programs. The contract has no...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWX62
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,624.91 delivery order is for the supply of KERENDIA 10 MG TABLET 30S, a pharmaceutical product, to support military treatment facilities and other government healthcare providers. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities. The contract does not have a set-aside designation and is for a firm fixed price with an ultimate completion date of September 12, 2024.

Generated 12/11/24, 9:17 AM